Growth Metrics

Globus Medical (GMED) Long-Term Deferred Tax (2016 - 2026)

Globus Medical filings provide 14 years of Long-Term Deferred Tax readings, the most recent being $218.2 million for Q4 2025.

  • On a quarterly basis, Long-Term Deferred Tax rose 131.65% to $218.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $218.2 million, a 131.65% increase, with the full-year FY2025 number at $218.2 million, up 131.65% from a year prior.
  • Long-Term Deferred Tax hit $218.2 million in Q4 2025 for Globus Medical, down from $232.4 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $275.9 million in Q2 2025 to a low of $7.3 million in Q3 2023.
  • Median Long-Term Deferred Tax over the past 5 years was $39.9 million (2022), compared with a mean of $67.6 million.
  • Biggest five-year swings in Long-Term Deferred Tax: tumbled 83.64% in 2023 and later soared 1416.0% in 2025.
  • Globus Medical's Long-Term Deferred Tax stood at $24.5 million in 2021, then skyrocketed by 99.42% to $48.8 million in 2022, then plummeted by 78.12% to $10.7 million in 2023, then surged by 781.61% to $94.2 million in 2024, then soared by 131.65% to $218.2 million in 2025.
  • The last three reported values for Long-Term Deferred Tax were $218.2 million (Q4 2025), $232.4 million (Q3 2025), and $275.9 million (Q2 2025) per Business Quant data.